Estados Unidos · Plataformas y datos · The Motley Fool

Elevance: 3 Key Takeaways for Long-Term Investors

Publicado por The Motley Fool · Estados Unidos hace 3 h

Clinical efficiency gains and integrated pharmacy benefits are lengthening the runway for margin expansion beyond 2026.

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

También te puede interesar

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Nokia reports 9% Q3 sales growth, raises restructuring costs

SPCX Stock Eyes Best Week In Nearly 3 Months — But Analyst Warns Investors May Have To ‘Wait Decades’ To Justify Its Valuation

Meta Found a Way to Raise Money Without Handing Out More Votes